This week on CUTalks, we are speaking to Sir Menelas Pangalos, the VP of BioPharmaceuticals R&D at AstraZeneca. He holds a PhD in neuroscience from UCL and has previously worked at Wyeth and Pfizer. We spoke about the importance of collaboration with academia, how AstraZeneca’s drug development success rate has increased in recent years and how they make sure medicines are accessible to all.

To find out more about CUTEC, visit https://www.cutec.io/